Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wei

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
BMC Cancer|April 18, 2015
Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support personsJamie Bryant, Rob Sanson-Fisher, William Stevenson, et al.
The Lancet. Haematology|October 23, 2021
Harnessing the benefits of available targeted therapies in acute myeloid leukaemiaHagop Kantarjian, Nicholas J Short, Courtney DiNardo, et al.
British Journal of Haematology|February 4, 2015
Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemiaAndrew Wei, Peter Tan, Sarah Perruzza, et al.
Leukemia & Lymphoma|December 3, 2011
Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysisAngela Y-C Tan, Stephen Q Wong, Charlotte Guldborg Nyvold, et al.
Journal of Materials Chemistry. B|April 9, 2020
Thiol-epoxy/maleimide ternary networks as softening substrates for flexible electronicsRadu Reit, Haley Abitz, Neel Reddy, et al.
European Journal of Haematology|May 3, 2018
Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabineAshvind Prabahran, Mark Tacey, Shaun Fleming, et al.
American Journal of Hematology|August 29, 2015
Immunological markers for prognostication in cytogenetically normal acute myeloid leukemiaVictoria Y Ling, Denise Lee, Zoe Mcquilten, et al.
Comprehensive Psychiatry|November 30, 2010
Validation of Patient Health Questionnaire for depression screening among primary care patients in TaiwanShen-Ing Liu, Zai-Ting Yeh, Hui-Chun Huang, et al.
Journal of Geriatric Oncology|July 28, 2020
Outcomes and health care utilization of older patients with acute myeloid leukemiaKirsty Sharplin, Li Yan A Wee, Deepak Singhal, et al.
Leukemia Research|April 6, 2025
Response to venetoclax in patients with blastic plasmacytoid dendritic cell neoplasmKirsty M Sharplin, Catherine Vassiliou, James Nguyen, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
BMC Cancer|April 18, 2015
Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support personsJamie Bryant, Rob Sanson-Fisher, William Stevenson, et al.
The Lancet. Haematology|October 23, 2021
Harnessing the benefits of available targeted therapies in acute myeloid leukaemiaHagop Kantarjian, Nicholas J Short, Courtney DiNardo, et al.
British Journal of Haematology|February 4, 2015
Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemiaAndrew Wei, Peter Tan, Sarah Perruzza, et al.
Leukemia & Lymphoma|December 3, 2011
Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysisAngela Y-C Tan, Stephen Q Wong, Charlotte Guldborg Nyvold, et al.
Journal of Materials Chemistry. B|April 9, 2020
Thiol-epoxy/maleimide ternary networks as softening substrates for flexible electronicsRadu Reit, Haley Abitz, Neel Reddy, et al.
European Journal of Haematology|May 3, 2018
Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabineAshvind Prabahran, Mark Tacey, Shaun Fleming, et al.
American Journal of Hematology|August 29, 2015
Immunological markers for prognostication in cytogenetically normal acute myeloid leukemiaVictoria Y Ling, Denise Lee, Zoe Mcquilten, et al.
Comprehensive Psychiatry|November 30, 2010
Validation of Patient Health Questionnaire for depression screening among primary care patients in TaiwanShen-Ing Liu, Zai-Ting Yeh, Hui-Chun Huang, et al.
Journal of Geriatric Oncology|July 28, 2020
Outcomes and health care utilization of older patients with acute myeloid leukemiaKirsty Sharplin, Li Yan A Wee, Deepak Singhal, et al.
Leukemia Research|April 6, 2025
Response to venetoclax in patients with blastic plasmacytoid dendritic cell neoplasmKirsty M Sharplin, Catherine Vassiliou, James Nguyen, et al.
Pageof 10